Simultaneously, the protein level of TRPV1 is upregulated in NSCLC clinical samples, and high expression of TRPV1 showed a tendency towards a poor prognosis, which indicated that TRPV1 expression could contribute to NSCLC progression. The gene discussed is TRPV1; the disease is non-small cell lung carcinoma.